Administrative Core

Catherine Klapperich, Ph.D., FTCC Director

Dr. Klapperich is a Kern Innovation Faculty Fellow and an Associate Professor of Biomedical Engineering at Boston University. She also holds appointments in the Division of Materials Science and Engineering and the Department of Mechanical Engineering. She is the Director of the Laboratory for Diagnostics and Global Healthcare Technologies and a member of the Center for Nanoscience and Nanotechnology.

Helen Fawcett, Ph.D., Administrative Core Technical Director

Dr. Fawcett is a Research Assistant Professor in the Department of Mechanical Engineering at BU.  She is the main contact point for members of the center and those looking to become involved with the center.  Her research interests include biodetection, optics and nanoscale lithography and imaging. She has served as the technical program manger on several large NIH and NSF grants.

Rhoda Alani, M.D., Co-PI

Dr. Alani is the Director of the Laboratory of Melanoma Biology, and Chair of Dermatology at Boston University School of Medicine.  She has authored over 50 peer-reviewed articles. She has been the director of several NIH-funded research projects in skin cancer biology and served on study sections for the NCI relevant to these areas of investigation.

Bennett Goldberg, Ph.D., Co-PI

Dr. Goldberg is a co-founder and Director of the Center for Nanoscience and Nanobiotechnology. He is currently the PI on the Boston University led training grant, R25: Cross-disciplinary Training in Nanotechnology for Cancer. He has published more than 150 peer-reviewed manuscripts and given more than 50 invited presentations.  His current research activities involve nanoscale imaging and spectroscopy of sub-cellular systems, novel interferomety for high-throughput, label-free microarrays, and development of nanomaterials for energy applications.

David Seldin, M.D., Ph.D., Co-PI

Dr. Seldin is Professor of Medicine and Microbiology, Director of the Graduate Program in Molecular Medicine and Chief of the Section of Hematology-Oncology at Boston University School of Medicine. His laboratory uses transgenic and knockout mouse models to complement biochemical and cell biological studies of the role of serine-threonine kinases in cellular growth control.  He serves as director of the Translational Technologies and Resources Program for the BU Clinical and Translational Science Institute (CTSI) and is Co-Chair of the Core Advisory Committee. Previously, Dr. Seldin has chaired the Transgenic Animal Committee and served on the Institutional Review Board and the General Clinical Research Unit Advisory Committee at CTSI.


Clinical Needs Assessment Core

The Clinical Needs Assessment Core is focused on identifying unmet needs as perceived by clinicians, patients, patient advocates and the medical device marketplace.

Renuka Babu Brown

Franklin Huang, M.D., Ph.D.

Dr. Huang is a fellow in the Department of Medical Oncology at the Dana-Farber Cancer Institute. Dr. Huang has a background in molecular biology, genetics and global health, with specific training and expertise in cancer in resource-limited settings.  He has been the PI on two studies in Dominica, where he led the implementation of an HIV/AIDS education program and investigated factors influencing pre-natal testing in pregnant women. He also works in Rwanda as a consulting oncologist with Partners in Health.


Training Core

The Training Core will offer workshops and meetups that bring the broad range of stakeholders together in settings where cross-fertilization of ideas can be facilitated. The Training Core will also select investigators as Innovation Fellows to receive summer sabbatical funding specifically for exploring the clinical and market potential of a new cancer diagnostic, treatment, or monitoring technology.

Jennifer Rosen, M.D.

Dr. Rosen is the Laszlo N. Tauber Assistant Professor of Surgery at Boston University. Her laboratory is focused on thyroid nodules and breast tumors, in particular the prediction of benign from malignant disease based on gene expression with an interest in identifying the roles these genes have on carcinogenesis.  She has been actively engaged in the Coulter Translational Research Partnership and the Fraunhofer/BU Alliance for Diagnostics, Medical Devices, and Instrumentation. Dr. Rosen has taught a short course titled “An Introduction to Cancer Care for Engineers and Physical Scientists,” in  2011 and 2012, and lectures in the School of Medicine on translational technologies in medicine.

Muhammad Zaman, Ph.D.

Muhammad Zaman is a Kern Innovation Faculty Fellow, Innovative Engineering Education Faculty Fellow and Associate Professor of Biomedical Engineering and Medicine at Boston University. At BU, he is the director of Laboratory of Engineering Education and Development and PI of Cellular and Molecular Dynamics Lab. His lab focuses on developing new experimental and computational technologies for high value healthcare problems in both the developing and developed world. He is currently involved in setting up the first biomedical engineering department at the University of Zambia in Lusaka.

Bennett Goldberg, Ph.D.


Prototyping Core

Alexis Sauer-Budge, Ph.D., Beta Core Co-Director

Dr. Sauer-Budge is a Senior Scientist at the Fraunhofer Center for Manufacturing Innovation (FCMI) and the program manager for the Boston University-Fraunhofer Alliance for Diagnostics, Medical Devices, and Instrumentation, a translational program designed to accelerate promising technologies from the research stage to the marketplace. This program has served as a model program for the FTCC translational core. The program’s successes include several spin-out companies and licenses to large companies after CMI built market-focused prototype devices and instruments.

Andre Sharon, Ph.D., Beta Core Co-Director

Dr. Sharon has an extensive background in the design of high precision, sub-micron, automated instrumentation, from the research level all the way to commercialization. At FCMI, he has overseen the development of several microfluidic, “Lab on a Chip” platforms and automated instruments for molecular diagnostics. Under a large DARPA grant, he recently developed and deployed a first-of-a-kind, fully automated factory for the production of plant-based pharmaceuticals. He established and leads the Boston University-Fraunhofer Alliance for Medical Devices, Instrumentation and Diagnostics.

Sharon Wong, Ph.D., Alpha Core Director